Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country.

International Journal of Clinical Practice
Nur Adila AnuarGin Gin Gan

Abstract

To retrospectively report the clinical outcomes of non-Hodgkin's Lymphoma (NHL) patients post high dose therapy (HDT) with autologous haematopoietic stem cell transplant (AHSCT) and determine whether upfront transplant, which is a first-line consolidative treatment with induction chemotherapy, would be a feasible modality in a resource-limited country. The medical records for NHL patients who had undergone HDT followed by AHSCT from October 1997 to November 2016 from two hospitals in Klang Valley, Malaysia were obtained from the medical record database and analysed retrospectively through statistical analysis. A total of 148 patients were retrospectively identified post-AHSCT, where the majority of whom had B cell lymphoma (53.4%). Majority of patients (88.5%) were in complete remission before AHSCT. The overall survival (OS) and event-free survival (EFS) at 3 years were 68.9% and 60.8%, respectively. The major cause of death was disease progression at 73.9%, while transplant-related mortality was 15.2%, with a median follow-up period of 179.5 weeks. Our study illustrates the promising outcomes of HDT with AHSCT in NHL patients in a resource-limited country. We recommend larger studies to be conducted in the future with a longe...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseUNKNOWN Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M D CaballeroE Conde
Oct 4, 2003·BMJ : British Medical Journal·Susan Mayor
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat
Sep 10, 2005·Blood·Lindsay M MortonMartha S Linet
Nov 12, 2005·CA: a Cancer Journal for Clinicians·James O Armitage
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marita ZiepertMarkus Loeffler
Jul 27, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Denise M OlianskyTheresa Hahn
Nov 8, 2011·Expert Opinion on Medical Diagnostics·Yawei ZhangShuangge Ma
Oct 8, 2013·Experimental Hematology·Nishitha M ReddyBipin N Savani
Nov 1, 2013·The New England Journal of Medicine·Patrick J StiffRichard I Fisher
Jun 3, 2015·Stem Cells Translational Medicine·Natasha AliMohammad Usman Shaikh
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H TillyUNKNOWN ESMO Guidelines Committee
Jul 28, 2016·Oncology·Reena NairMohandas K Mallath
Mar 5, 2018·International Journal of Hematology·Hiroaki Miyoshi, Koichi Ohshima
Jun 20, 2018·Frontiers in Oncology·Timothy M PierpontKristy L Richards
Sep 1, 2019·Bone Marrow Transplantation·Yara Abrão Vasconcelos VivasAbrahão Elias Hallack Neto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Tontanai Numbenjapon, Auayporn Nademanee
Multiple Sclerosis : Clinical and Laboratory Research
Sophie ChattertonJennifer C Massey
Multiple Sclerosis and Related Disorders
Floriaan G C M De KleermaekerBob W van Oosten
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Christopher LemieuxSilvy Lachance
© 2021 Meta ULC. All rights reserved